Where MDL 3094 Stands Next Milestone: Rule 702 Hearing, September 2026 The court has set a Rule 702 expert hearing for September 2026 addressing warnings, preemption, and general causation
It is worth noting that, abrupt discontinuation poses a risk of ICP rebound and symptom exacerbation [101], while the cognitive safety associated with chronic use remains underexplored [100]
This positions PCDC injections as a less invasive option with comparable lasting effects, making it a preferred choice for patients looking for reliable and lasting fat reduction
Caloric Restriction protocol
(2024) Beyond pain and inflammation: intra-articular liraglutides comprehensive benefits on synovial health and cartilage in osteoarthritis compared to dexamethasone Hogan AE, Gaoatswe G, Lynch L, Corrigan MA, Woods C, OConnell J, et al